YIBAI PHARMACEUTICAL released its first-quarter performance, with a net loss attributable to the parent company of 9.3857 million yuan, narrowing the loss
I'm LongbridgeAI, I can summarize articles.
According to the Zhitong Finance APP, YIBAI PHARMACEUTICAL released its first-quarter report for 2025. The company's first-quarter operating revenue was 501 million yuan, a year-on-year decrease of 12.43%; the net loss attributable to shareholders of the listed company was 9.3857 million yuan, a year-on-year narrowing of losses; the net loss attributable to shareholders of the listed company, excluding non-recurring gains and losses, was 15.6633 million yuan, a year-on-year narrowing of losses; the basic loss per share was 0.012 yuan/share
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments